Aplexis Inc.

Wilmette, IL

UEI
Q314G2UGRGL5
CAGE
8UX62
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
342 Beverly Dr, Wilmette, IL 60091, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Developing small molecule inhibitors of pleckstrin-2 to treat thrombosis R44HL165997 National Heart Lung and Blood Institute (NIH) $4,405,348
Developing small molecule inhibitors of pleckstrin-2 to treat thrombosis R43HL165997 National Heart Lung and Blood Institute (NIH) $794,395

Quick answers

Is Aplexis Inc. registered in SAM.gov?

Yes. Aplexis Inc.'s SAM.gov registration is active through May 14, 2027.

What is Aplexis Inc.'s most recent federal award?

Aplexis Inc.'s most recent federal grant award is Developing small molecule inhibitors of pleckstrin-2 to treat thrombosis (R44HL165997), from National Heart Lung and Blood Institute (NIH), on September 15, 2022.

On GovTribe

See Aplexis Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login